Rigel Pharmaceuticals, Inc. Surges 39% On Agreement With Bristol-Myers Squibb

Following the surge in stock price, here is what you need to know about Rigel's latest development.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.